Philips Healthcare Philips Azurion systems with software releases 2.1(L1) and 2.1(L2) Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Philips Azurion systems with software releases 2.1(L1) and 2.1(L2)
Brand
Philips Healthcare
Lot Codes / Batch Numbers
Azurion 2.1(L1) and 2.1(L2)
Products Sold
Azurion 2.1(L1) and 2.1(L2)
Philips Healthcare is recalling Philips Azurion systems with software releases 2.1(L1) and 2.1(L2) due to 3D-RA is a reconstruction software product that can be used with the Philips Azurin system. This product extends the functionality of compatible X-ray. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
3D-RA is a reconstruction software product that can be used with the Philips Azurin system. This product extends the functionality of compatible X-ray equipment with the capability of 3D X-ray imaging. Before starting a 3D-RA scan, the detector of the Philips Azurion system must be positioned in portrait or landscape orientation with an angle of 0 or +/-90 degrees relative to the 3D scan direction. Philips has discovered that Azurion releases 2.1(L1) and 2.1(L2) allow creation of a 3D-RA scan with a deviating detector orientation of up to 3 degrees from the exact portrait or landscape orientation (i.e., at 0 or +/-90 degrees), relative to the 3D scan direction. 3D-RA scans with a deviating detector orientation of ore than 1.0 degree from the exact portrait or landscape orientation (i.e., at 0 or +/-90 degrees) cannot be reconstructed with the 3D-RA reconstruction software.
Recommended Action
Per FDA guidance
Philips will inform customers of the issue via an Electronic Product Radiation Correction notification. The letter identified the affected product, problem and actions to be taken. Philips Field Service Engineers will schedule an appointment with customers to install the software update. For questions contact your Philips representative at 1-800-722-9377.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026